Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 1 - 10 of about 180   

Articles published

AZN 4,274.00 -42.50 (-0.98%)
price chart
What Happens If Pfizer Inc. Doesn't Come Back For AstraZeneca plc?
Since May, AstraZeneca's (LSE: AZN) (NYSE: AZN.US) shareholders have been excitedly awaiting the return of Pfizer to make a new buyout offer for the UK's second largest pharmaceutical company.
GlaxoSmithKline PLC vs AstraZeneca PLC: Which Is The Better Dividend Play?  Yahoo Finance UK
AstraZeneca share price: Analysts see drugmaker as viable takeover target  iNVEZZ
Related articles »  
Is AstraZeneca plc A Promising Capital-Growth Investment?
astrazeneca2 The pharmaceutical industry continues to attract for its 'defensive' qualities and AstraZeneca (LSE: AZN) (NYSE: AZN.
Why I'd Still Buy AstraZeneca plc Despite Shire PLC Deal Collapse
2014 has been a superb year for investors in AstraZeneca (LSE: AZN). That's because shares in the pharmaceutical company have risen by 19% since the start of the year, which is well ahead of the FTSE 100′s disappointing decline of 6%.
Related articles »  
Is Now The Right Time To Buy AstraZeneca plc?
After all, AstraZeneca's share price has fallen by 6% since 23 September, when changes to US tax rules made a bid less financially attractive for US companies.
Related articles »  
Why Shire PLC, Hikma Pharmaceuticals Plc And BTG plc Could Complement ...
Of course, an obvious choice in the sector is AstraZeneca (LSE: AZN), due to its size, scale and improving pipeline. Indeed, the company is making significant improvements to its long term growth potential and has been on something of an acquisition ...
Related articles »  
Why You Should Let AstraZeneca plc Look After Your Money
AstraZeneca (LSE: AZN) (NYSE: AZN.US) is one of the world's largest pharmaceutical companies. It's produced some valuable products over the years, and that (if all goes well) looks set to continue.
5 Stunning Reasons Why GlaxoSmithKline plc And AstraZeneca plc Could ...
While investors in AstraZeneca (LSE: AZN) have experienced a very strong 2014 thus far, with shares in the pharmaceutical major gaining 27%, it's been a very different story for their counterparts in GlaxoSmithKline (LSE: GSK).
Why Smith & Nephew plc's Latest Failure Should Worry AstraZeneca plc And ...
Medical play Smith and Nephew (LSE: SN) disappointed the market on Monday when it announced that testing of its GlaxoSmithKline HP802-247 treatment in North America - a spray designed to treat veinous leg ulcers (or VLUs) - had failed at the Phase ...
Weekly Analysts' Ratings Changes for AstraZeneca plc (AZN)
Shares of AstraZeneca plc (NYSE:AZN) opened at 69.00 on Wednesday. AstraZeneca plc has a 1-year low of $51.92 and a 1-year high of $82.68.
AstraZeneca plc (AZN) - Research Analysts' Recent Ratings Updates
AstraZeneca plc was upgraded by analysts at Jefferies Group to a �buy� rating. They now have a GBX 5,000 ($80.46) price target on the stock, up previously from GBX 4,500 ($72.42).
AstraZeneca plc Rating Reiterated by Credit Suisse (AZN)  WKRB News
Morningstar Assigns "AA-" Credit Rating to AstraZeneca plc (AZN)  Watch List News (press release)
Related articles »